Arax Advisory Partners’s BlackRock Health Sciences Trust BME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$18.4K Hold
479
﹤0.01% 2133
2025
Q4
$19.7K Hold
479
﹤0.01% 2120
2025
Q3
$17.8K Buy
+479
New +$17.4K ﹤0.01% 2317

Other funds holding BME

Arax Advisory Partners's BME Position: Q1 2026 in Review

Arax Advisory Partners held its BlackRock Health Sciences Trust (BME) position steady in Q1 2026 at 479 shares worth $18.4K. The position accounts for ﹤0.01% of the portfolio, ranked #2133.

Arax Advisory Partners first reported a position in BME in Q3 2025 and has held it in 3 quarters since. The position peaked at $19.7K in Q4 2025. 76 funds tracked by Wall St. Rank hold BME as of Q1 2026.

  • Arax Advisory Partners held 479 shares of BlackRock Health Sciences Trust worth $18.4K as of Q1 2026.
  • Arax Advisory Partners left its BlackRock Health Sciences Trust share count unchanged in Q1 2026.
  • BlackRock Health Sciences Trust made up ﹤0.01% of Arax Advisory Partners's portfolio in Q1 2026, its #2133 holding.
  • Arax Advisory Partners first reported a position in BlackRock Health Sciences Trust in Q3 2025 and has held it in 3 quarters since.
  • Arax Advisory Partners's BlackRock Health Sciences Trust position peaked at $19.7K in Q4 2025.
  • 76 funds tracked by Wall St. Rank held BlackRock Health Sciences Trust as of Q1 2026.

Based on Arax Advisory Partners's 13F filing for Q1 2026, filed 13 May 2026.